NUZTF Intrinsic Valuation and Fundamental Analysis - Neurizon Therapeutics Ltd - Alpha Spread

Watchlist Manager

Watchlist

Price: 0.047 USD Market Closed

Market Cap: $25.1m

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value for Neurizon Therapeutics Ltd.

Do our valuations actually work? See backtest results .

Fundamental Analysis

What Neurizon Therapeutics Does

Pharmaceuticals Health Care

Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-10-05. The firm is engaged in advancing treatments for neurodegenerative diseases.

Headquarters: Australia AU
IPO date: Oct 5, 2001

Read the full company overview

View Company Overview

Jun 2016 Dec 2016 Jun 2017 Dec 2017 Jun 2018 Dec 2018 Jun 2019 Dec 2019 Jun 2020 Dec 2020 Jun 2021 Dec 2021 Jun 2022 Dec 2022 Jun 2023 Dec 2023 Jun 2024 Dec 2024 Jun 2025 Jun 2026

Wall St Price Targets

Capital Returns

Competitive Landscape

Continue NUZTF Research

Relative Valuation

Wall St Estimates

Financial Statements

Join 361,400+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.